title: Structural basis for the functional roles of critical residues in human cytochrome p450 aromatase.
abstract: Cytochrome P450 aromatase (CYP19A1) is the only enzyme known to catalyze the biosynthesis of estrogens from androgens. The crystal structure of human placental aromatase (pArom) has paved the way toward understanding the structure-function relationships of this remarkable enzyme. Using an amino terminus-truncated recombinant human aromatase (rArom) construct, we investigate the roles of key amino acids in the active site, at the intermolecular interface, inside the access channel, and at the lipid-protein boundary for their roles in enzyme function and higher-order organization. Replacing the active site residue D309 with an N yields an inactive enzyme, consistent with its proposed involvement in aromatization. Mutation of R192 at the lipid interface, pivotal to the proton relay network in the access channel, results in the loss of enzyme activity. In addition to the distal catalytic residues, we show that mutation of K440 and Y361 of the heme-proximal region critically interferes with substrate binding, enzyme activity, and heme stability. The D-E loop deletion mutant Del7 that disrupts the intermolecular interaction significantly reduces enzyme activity. However, the less drastic Del4 and point mutants E181A and E181K do not. Furthermore, native gel electrophoresis, size-exclusion chromatography, and analytical ultracentrifugation are used to show that mutations in the intermolecular interface alter the quaternary organization of the enzyme in solution. As a validation for interpretation of the mutational results in the context of the innate molecule, we determine the crystal structure of rArom to show that the active site, tertiary, and quaternary structures are identical to those of pArom.
authors.affiliation: Department of Pharmacology, SUNY Upstate Medical University, Syracuse, New York 13210, United States.
authors.forename: Jessica
authors.initials: J
authors.lastname: Lo
authors.forename: Giovanna
authors.initials: G
authors.lastname: Di Nardo
authors.forename: Jennifer
authors.initials: J
authors.lastname: Griswold
authors.forename: Chinaza
authors.initials: C
authors.lastname: Egbuta
authors.forename: Wenhua
authors.initials: W
authors.lastname: Jiang
authors.forename: Gianfranco
authors.initials: G
authors.lastname: Gilardi
authors.forename: Debashis
authors.initials: D
authors.lastname: Ghosh
mesh_terms: D000595:Amino Acid Sequence; D001141:Aromatase / Q000737:chemistry* / Q000235:genetics; D047072:Aromatase Inhibitors / Q000737:chemistry; D020134:Catalytic Domain; D003460:Crystallization; D005260:Female; D006801:Humans; D007700:Kinetics; D010920:Placenta / Q000201:enzymology; D011247:Pregnancy; D020836:Protein Structure, Quaternary; D011994:Recombinant Proteins / Q000737:chemistry; D014961:X-Ray Diffraction
chemical_list: D047072:Aromatase Inhibitors; D011994:Recombinant Proteins; D001141:Aromatase
references.citation: Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):410-4
references.pmid: 1988941
references.citation: J Biol Chem. 2011 Feb 4;286(5):3359-69
references.pmid: 21106533
references.citation: J Pharm Biomed Anal. 2005 Jun 15;38(2):307-12
references.pmid: 15925223
references.citation: J Steroid Biochem Mol Biol. 2010 Feb 28;118(4-5):197-202
references.pmid: 19808095
references.citation: Steroids. 2004 Apr;69(4):235-43
references.pmid: 15183689
references.citation: Eur J Biochem. 2001 Jan;268(2):243-51
references.pmid: 11168357
references.citation: Nature. 2009 Jan 8;457(7226):219-23
references.pmid: 19129847
references.citation: Mol Endocrinol. 2007 Feb;21(2):401-14
references.pmid: 17095574
references.citation: Methods Mol Biol. 2011;705:109-22
references.pmid: 21125383
references.citation: Biochem Biophys Res Commun. 1994 Jun 15;201(2):694-700
references.pmid: 8003004
references.citation: Biotechnol Appl Biochem. 2013 Jan-Feb;60(1):92-101
references.pmid: 23586996
references.citation: Endocr Res. 1990;16(2):255-67
references.pmid: 2140551
references.citation: J Steroid Biochem Mol Biol. 1993 Aug;46(2):147-53
references.pmid: 8664162
references.citation: Endocr Rev. 2009 Jun;30(4):343-75
references.pmid: 19389994
references.citation: J Steroid Biochem Mol Biol. 1993 Mar;44(4-6):347-56
references.pmid: 8476748
references.citation: Biophys J. 2000 Mar;78(3):1606-19
references.pmid: 10692345
references.citation: Biochem Pharmacol. 2002 Nov 1;64(9):1317-24
references.pmid: 12392814
references.citation: J Biol Chem. 1994 Jul 29;269(30):19501-8
references.pmid: 8034720
references.citation: Biochem Pharmacol. 2008 Mar 1;75(5):1161-9
references.pmid: 18184606
references.citation: J Comput Chem. 2004 Oct;25(13):1605-12
references.pmid: 15264254
references.citation: PLoS One. 2012;7(2):e32565
references.pmid: 22384274
references.citation: Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55
references.pmid: 15299926
references.citation: Science. 2004 Jul 30;305(5684):683-6
references.pmid: 15256616
references.citation: Mol Endocrinol. 2009 Oct;23(10):1634-45
references.pmid: 19556341
references.citation: Cancer Res. 1990 Nov 1;50(21):6949-54
references.pmid: 2208160
references.citation: Biochemistry. 2012 Apr 10;51(14):3039-49
references.pmid: 22439696
references.citation: Eur J Biochem. 2002 Mar;269(5):1393-405
references.pmid: 11874453
references.citation: Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
references.pmid: 15572765
references.citation: Ann N Y Acad Sci. 2009 Feb;1155:112-20
references.pmid: 19250198
references.citation: J Steroid Biochem Mol Biol. 2004 Mar;88(3):235-45
references.pmid: 15120417
references.citation: Steroids. 2011 Jul;76(8):753-8
references.pmid: 21392520